Midodrine, Adrenergic Agonists and Antagonists

[1]  A. Diedrich,et al.  Comparative Efficacy of Yohimbine Against Pyridostigmine for the Treatment of Orthostatic Hypotension in Autonomic Failure , 2010, Hypertension.

[2]  J. Handrakis,et al.  Effects of midodrine hydrochloride on blood pressure and cerebral blood flow during orthostasis in persons with chronic tetraplegia. , 2010, Archives of physical medicine and rehabilitation.

[3]  M. Lamarre-Cliche,et al.  Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study. , 2008, Clinical therapeutics.

[4]  S. Ghosh-Dastidar,et al.  Autonomie Mechanisms and Therapeutic Implications of Postural Diabetic Cardiovascular Abnormalities , 2008, Journal of diabetes science and technology.

[5]  I. Schatz.  Treating blood pressure in familial dysautonomia , 2005, Clinical autonomic research : official journal of the Clinical Autonomic Research Society.

[6]  L. Rolnitzky,et al.  Fludrocortisone in patients with familial dysautonomia , 2005, Clinical Autonomic Research.

[7]  A. Garg,et al.  Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  B. Grubb,et al.  Clinical Disorders of the Autonomic Nervous System Associated with Orthostatic Intolerance: An Overview of Classification, Clinical Evaluation, and Management , 1999, Pacing and clinical electrophysiology : PACE.

[9]  S. Hohnloser,et al.  Prospective Evaluation of a Two‐Step Therapeutic Strategy in Neurocardiogenic Syncope: Midodrine as Second Line Treatment in Patients Refractory to β‐Blockers , 1999, Pacing and clinical electrophysiology : PACE.

[10]  P. Low,et al.  A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension , 1998, Neurology.

[11]  R. Kenny,et al.  Midodrine: a role in the management of neurocardiogenic syncope , 1998, Heart.

[12]  R. Freeman,et al.  Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. , 1997, JAMA.

[13]  F. Fouad-Tarazi,et al.  Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. , 1995, The American journal of medicine.

[14]  D. Robertson,et al.  Recent advances in the treatment of orthostatic hypotension. , 1995, Neurology.

[15]  S E Piwinski,et al.  A Comparison of Postspace‐Flight Orthostatic Intolerance to Vasovagal Syncope and Autonomic Failure and the Potential Use of the Alpha Agonist Midodrine for These Conditions , 1994, Journal of clinical pharmacology.

[16]  J. Jankovic,et al.  Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. , 1993, The American journal of medicine.

[17]  G. Jl.  Midodrine in neurogenic orthostatic hypotension. A new treatment. , 1993 .

[18]  K. Goa,et al.  Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. , 1989, Drugs.

[19]  M. Yahr,et al.  Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha‐adrenergic agonist (midodrine) , 1988, Neurology.

[20]  H. Aihara,et al.  Effects of midodrine on experimentally-induced postural hypotension in dogs. , 1986, Arzneimittel-Forschung.

[21]  M. Goldberg,et al.  Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system. , 1986, The Journal of clinical investigation.

[22]  Scholing We.  [Studies on the effect of the alpha-receptor stimulant, gutron, in the orthostatic syndrome (author's transl)]. , 1981 .